Nikhil Lalwani - 11 Aug 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
11 Aug 2023
Net transactions value
-$3,982,548
Form type
4
Filing time
15 Aug 2023, 20:39:03 UTC
Previous filing
27 Mar 2023
Next filing
11 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $3,272,462 -56,666 -14% $57.75 353,390 11 Aug 2023 Direct
transaction ANIP Common Stock Options Exercise $336,864 +11,616 +3.3% $29.00 365,006 15 Aug 2023 Direct
transaction ANIP Common Stock Sale $710,086 -11,616 -3.2% $61.13 353,390 15 Aug 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise $336,864 -11,616 -6.5% $29.00 168,027 15 Aug 2023 Common Stock 11,616 $29.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $60.68 to $61.87, inclusive.
F2 25% of the total options vested on each of September 8, 2021 and September 8, 2022. 25% of the total options will vest on each of September 8, 2023 and September 8, 2024.